256 related articles for article (PubMed ID: 15048610)
21. Identifying psychiatric patients with serotonergic dysfunctions by event-related potentials.
Hegerl U; Juckel G
World J Biol Psychiatry; 2000 Apr; 1(2):112-8. PubMed ID: 12607207
[TBL] [Abstract][Full Text] [Related]
22. The loudness dependence of the auditory evoked potential (LDAEP) as an in vivo biomarker of central serotonergic function in humans: rationale, evaluation and review of findings.
O'Neill BV; Croft RJ; Nathan PJ
Hum Psychopharmacol; 2008 Jul; 23(5):355-70. PubMed ID: 18421800
[TBL] [Abstract][Full Text] [Related]
23. Auditory evoked dipole source activity: indicator of central serotonergic dysfunction in psychiatric patients?
Hegerl U; Juckel G
Pharmacopsychiatry; 1994 Mar; 27(2):75-8. PubMed ID: 8029316
[TBL] [Abstract][Full Text] [Related]
24. No association between chronic cannabis use and loudness dependence of auditory evoked potentials as indicator of central serotonergic neurotransmission.
Roser P; Della B; Norra C; Juckel G; Uhl I
Neurosci Lett; 2009 Nov; 465(2):113-7. PubMed ID: 19766579
[TBL] [Abstract][Full Text] [Related]
25. Lithium therapy for unipolar and bipolar depression among the middle-aged and older adult patient subpopulation.
Lepkifker E; Iancu I; Horesh N; Strous RD; Kotler M
Depress Anxiety; 2007; 24(8):571-6. PubMed ID: 17133442
[TBL] [Abstract][Full Text] [Related]
26. Determination of the loudness dependence of auditory evoked potentials: single-electrode estimation versus dipole source analysis.
Hagenmuller F; Hitz K; Darvas F; Kawohl W
Hum Psychopharmacol; 2011 Mar; 26(2):147-54. PubMed ID: 21455973
[TBL] [Abstract][Full Text] [Related]
27. Carbamazepine as adjunct or alternative to lithium in the prophylaxis of recurrent affective disorders.
Fritze J; Beneke M; Lanczik M; Schneider B; Walden J
Pharmacopsychiatry; 1994 Sep; 27(5):181-5. PubMed ID: 7838887
[TBL] [Abstract][Full Text] [Related]
28. The Loudness Dependence of Auditory Evoked Potentials (LDAEP) in individuals at risk for developing bipolar disorders and schizophrenia.
Hagenmuller F; Heekeren K; Meier M; Theodoridou A; Walitza S; Haker H; Rössler W; Kawohl W
Clin Neurophysiol; 2016 Feb; 127(2):1342-1350. PubMed ID: 26639170
[TBL] [Abstract][Full Text] [Related]
29. Further evidence for a possible association between serotonin transporter gene and lithium prophylaxis in mood disorders.
Serretti A; Malitas PN; Mandelli L; Lorenzi C; Ploia C; Alevizos B; Nikolaou C; Boufidou F; Christodoulou GN; Smeraldi E
Pharmacogenomics J; 2004; 4(4):267-73. PubMed ID: 15111989
[TBL] [Abstract][Full Text] [Related]
30. Event-related potentials. Do they reflect central serotonergic neurotransmission and do they predict clinical response to serotonin agonists?
Hegerl U; Gallinat J; Juckel G
J Affect Disord; 2001 Jan; 62(1-2):93-100. PubMed ID: 11172876
[TBL] [Abstract][Full Text] [Related]
31. Sound level dependence of the primary auditory cortex: Simultaneous measurement with 61-channel EEG and fMRI.
Mulert C; Jäger L; Propp S; Karch S; Störmann S; Pogarell O; Möller HJ; Juckel G; Hegerl U
Neuroimage; 2005 Oct; 28(1):49-58. PubMed ID: 16006148
[TBL] [Abstract][Full Text] [Related]
32. Effects of selective and combined serotonin and dopamine depletion on the loudness dependence of the auditory evoked potential (LDAEP) in humans.
O'Neill BV; Guille V; Croft RJ; Leung S; Scholes KE; Phan KL; Nathan PJ
Hum Psychopharmacol; 2008 Jun; 23(4):301-12. PubMed ID: 18213738
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the lithium RBC/plasma ratio as a predictor of the prophylactic effect of lithium treatment in affective disorders.
Knorring L; Oreland L; Perris C; Wiberg A
Pharmakopsychiatr Neuropsychopharmakol; 1976 Mar; 9(2):81-4. PubMed ID: 981325
[TBL] [Abstract][Full Text] [Related]
34. [Clinical predictors of long-term outcome of lithium prophylaxis in bipolar disorder].
Garcia-López A; Ezquiaga E; Nieves P; Rodríguez-Salvanés F
Actas Esp Psiquiatr; 2001; 29(5):327-32. PubMed ID: 11602090
[TBL] [Abstract][Full Text] [Related]
35. Loudness dependence of auditory evoked potentials as indicator of central serotonergic neurotransmission: simultaneous electrophysiological recordings and in vivo microdialysis in the rat primary auditory cortex.
Wutzler A; Winter C; Kitzrow W; Uhl I; Wolf RJ; Heinz A; Juckel G
Neuropsychopharmacology; 2008 Dec; 33(13):3176-81. PubMed ID: 18463629
[TBL] [Abstract][Full Text] [Related]
36. The intensity dependence of the auditory evoked N1 component as a predictor of response to Citalopram treatment in patients with major depression.
Linka T; Müller BW; Bender S; Sartory G
Neurosci Lett; 2004 Sep; 367(3):375-8. PubMed ID: 15337269
[TBL] [Abstract][Full Text] [Related]
37. The intensity dependence of auditory evoked ERP components predicts responsiveness to reboxetine treatment in major depression.
Linka T; Müller BW; Bender S; Sartory G; Gastpar M
Pharmacopsychiatry; 2005 May; 38(3):139-43. PubMed ID: 15902586
[TBL] [Abstract][Full Text] [Related]
38. Reduced plasma cyclic AMP level during prophylactic lithium treatment in patients with affective disorders.
Arató M; Rihmer Z; Felszeghy K
Biol Psychiatry; 1980 Apr; 15(2):319-22. PubMed ID: 6251928
[No Abstract] [Full Text] [Related]
39. Loudness dependence of the auditory evoked potential and response to antidepressants in Chinese patients with major depression.
Lee TW; Yu YW; Chen TJ; Tsai SJ
J Psychiatry Neurosci; 2005 May; 30(3):202-5. PubMed ID: 15944745
[TBL] [Abstract][Full Text] [Related]
40. A study of intensity dependence of the auditory evoked potential (IDAEP) in medicated melancholic and non-melancholic depression.
Fitzgerald PB; Mellow TB; Hoy KE; Segrave R; Cooper NR; Upton DJ; Croft RJ
J Affect Disord; 2009 Oct; 117(3):212-6. PubMed ID: 19201033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
